Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2016 Nov 29:6:37865.
doi: 10.1038/srep37865.

The incidence and drug resistance of Clostridium difficile infection in Mainland China: a systematic review and meta-analysis

Affiliations
Meta-Analysis

The incidence and drug resistance of Clostridium difficile infection in Mainland China: a systematic review and meta-analysis

Chenjie Tang et al. Sci Rep. .

Abstract

It has been widely reported that the incidence and severity of Clostridium difficile infection (CDI) have increased dramatically in North America and Europe. However, little is known about CDI in Mainland China. In this study, we aimed to investigate the incidence of CDI and the main epidemic and drug-resistant strains of C. difficile in Mainland China through meta-analysis of related studies published after the year 2010. A total of 51 eligible studies were included. The pooled incidence of toxigenic C. difficile among patients with diarrhoea was 14% (95% CI = 12-16%). In Mainland China, ST-37 and ST-3 were the most prevalent strains; fortunately, hypervirulent strains, such as ST-1 (BI/NAP1/027) and ST-11 (RT 078), have only occurred sporadically to date. The rates of C. difficile resistance to ciprofloxacin (98.3%; 95% CI = 96.9-99.7%), clindamycin (81.7%; 95% CI = 76.1-87.3%) and erythromycin (80.2%; 95% CI = 73.5-86.9%) are higher than in other counties; however, none of the C. difficile isolates reported in Mainland China were resistant to metronidazole (n/N = 0/960), vancomycin (n/N = 0/960), tigecycline (n/N = 0/41) or piperacillin/tazobactam(n/N = 0/288).

PubMed Disclaimer

Figures

Figure 1
Figure 1. Flow diagram of the procedures used to identify CDI studies in Mainland China.
Figure 2
Figure 2. Meta-analyses of CDI in Mainland China.
Figure 3
Figure 3. The incidence of CDI in Mainland China (Created by an online Chinese website.http://c.dituhui.com/apps/range).

References

    1. Bartlett J. G., Chang T. W., Gurwith M., Gorbach S. L. & Onderdonk A. B. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. The New England journal of medicine. 298, 531–534 (1978). - PubMed
    1. Moreno M. A., Furtner F. & Rivara F. P. Clostridium difficile: a cause of diarrhea in children. JAMA pediatrics. 167, 592 (2013). - PubMed
    1. Bartlett J. G. Clinical practice. Antibiotic-associated diarrhea. The New England journal of medicine. 346, 334–339 (2002). - PubMed
    1. O’Connor J. R., Johnson S. & Gerding D. N. Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain. Gastroenterology. 136, 1913–1924 (2009). - PubMed
    1. Cohen S. H. et al.. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infection control and hospital epidemiology. 31, 431–455 (2010). - PubMed

Publication types